How digital therapies can transform your health. Traditional health care has a new ally. Some patients with sleep disorders, back pain, and diabetes are now being prescribed app-based treatment instead of drugs. Algorithms are helping cancer patients manage their symptoms, and video games are improving the attention span of children diagnosed with ADHD. A new class of medicine called digital therapeutics (DTx) is gaining traction and transforming the way patients engage with the health care system. In Medicine without Meds, Dean Ho, Yoann Sapanel, and Agata Blasiak explore the exciting potential for these digital therapies to transform patient care. Ho, Sapanel, and Blasiak share their insights on how these therapies can deliver value beyond the technology, address the challenges of implementation in existing health care models, and revolutionize care delivery. These clinicians, researchers, engineers, patients, start-up founders, and corporate executives are at the forefront of designing and building tomorrow's DTx. They explain what DTx represents, how it differs from other digital health solutions, and how these tools can be conceptualized, created, and brought to market. Throughout, case studies from leading DTx organization such as Akili Interactive, MedRhythms, and Welldoc illuminate best practices in product development, issues to consider, and pitfalls to avoid. These essays, along with a foreword by D. A. Wallach and Dr. Eddie Martucci's outlook on the future of DTx, present the exciting potential for DTx to reimagine health care for all.
Dean Ho (SINGAPORE) is the Provost's Chair Professor, the Director of the Institute for Digital Medicine and the N.1 Institute for Health, and the Head of the Department of Biomedical Engineering at the National University of Singapore. Yoann Sapanel (SINGAPORE) is the Head of Health Innovation at the Institute for Digital Medicine at the National University of Singapore. Agata Blasiak (SINGAPORE) is the Head of Digital Health Innovation at the Institute for Digital Medicine and the N.1 Institute for Health at the National University of Singapore.
Foreword by D.A. Wallach: It is time for healthcare to embrace patients Preface Introduction: The Context Part I: What Are Digital Therapeutics? 1. Digital Health Solutions Versus Digital Therapeutics Part II: The Right Tool for The Right Problem 1. Addressing Unmet Stakeholder Needs 2. Addressing Unmet Clinical Needs 3. Ensuring Business Viability Early 4. Test, Learn, and Pivot Part III: From Pilot to Production 5. Data Sourcing and Management 6. Gathering Evidence: Novel Approaches to Clinical Validation 7. Factors That Influence the Implementation of New Technologies 8. Recommendations for DTx Implementation 9. Supporting Adoption of DTx Part IV: Paths to Commercialization 10. Channel Partnerships: The Ultimate Commercialization Strategy 11. The Price is Right:: Value in The Eye of The Beholder Conclusion by Dr Eddie Martucci: The Future of DTx Appendix Bibliography Acknowledgments Index
How digital therapies can transform your health.
This book shares useful resources, discusses insightful case studies (both successful and unsuccessful), and provides guidelines at various technology and business development stages. The case studies and key takeaways are particularly instrumental and enjoyable to read. The international coverage of the topic is another highlight of the book. I consider the book highly original, and it represents a substantial contribution to the digital therapeutic space. It should be a must-read. -Pak Kin Wong, PhD, The Pennsylvania State University
